House Panel Asks For ‘Prompt Review’ Of Evidence On Dense Breast Reporting
This article was originally published in The Gray Sheet
Executive Summary
The House Appropriations Committee May 29 approved a flat-level 2015 FDA spending bill. The committee’s report language for the bill urges the agency to expedite its review of evidence supporting the need for breast density reporting in individuals’ mammography reports, and to keep focus on artificial pancreas systems.